Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

ALLIANCE trial and the combinations of CYP17 and AR inhibitors in CRPC

Editor By No Comments1 Min Read

Dr. Nima Sharifi, MD at Cleveland Clinic discusses the ALLIANCE trial and the combinations of CYP17 and AR inhibitors in CRPC at ASCO GU 2016 in San francisco

Share.

Related Posts